Cullinan Therapeutics, Inc. (CGEM) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001789972 · SEC filings checked Oct 18, 2026
Next report
Not yet known
Fewer than three past results filings to estimate from.
Last close
$12.93
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Mar 31, 2026 | May 7, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Dec 31, 2025 | Mar 10, 2026 | Announced; figures arrive with the 10-Q | $-50.7M | — | Filing |
| Sep 30, 2025 | Nov 6, 2025 | Announced; figures arrive with the 10-Q | $-50.6M | — | Filing |
| Jun 30, 2025 | Aug 7, 2025 | Announced; figures arrive with the 10-Q | $-70.1M | — | Filing |
| Mar 31, 2025 | May 8, 2025 | Announced; figures arrive with the 10-Q | $-48.5M | — | Filing |
| Dec 31, 2024 | Feb 27, 2025 | Announced; figures arrive with the 10-Q | $-47.8M | — | Filing |
| Sep 30, 2024 | Nov 7, 2024 | — | $-40.6M | $-0.69 | Filing |
| Jun 30, 2024 | Aug 8, 2024 | — | $-42.0M | $-0.75 | Filing |
| Mar 31, 2024 | May 15, 2024 | — | $-37.1M | $-0.86 | Filing |
What would Cullinan Therapeutics, Inc. have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.